HighTower Advisors LLC Has $9.42 Million Stake in Corteva, Inc. (NYSE:CTVA)

HighTower Advisors LLC raised its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 165,368 shares of the company's stock after buying an additional 7,654 shares during the quarter. HighTower Advisors LLC's holdings in Corteva were worth $9,419,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp raised its position in shares of Corteva by 2.3% during the 3rd quarter. State Street Corp now owns 34,290,086 shares of the company's stock worth $2,015,914,000 after purchasing an additional 768,519 shares during the period. Geode Capital Management LLC raised its position in shares of Corteva by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 17,703,771 shares of the company's stock worth $1,037,505,000 after purchasing an additional 355,206 shares during the period. Franklin Resources Inc. raised its position in shares of Corteva by 6.1% during the 3rd quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock worth $860,746,000 after purchasing an additional 856,007 shares during the period. Harris Associates L P raised its position in shares of Corteva by 1.4% during the 3rd quarter. Harris Associates L P now owns 14,362,309 shares of the company's stock worth $844,360,000 after purchasing an additional 200,917 shares during the period. Finally, FMR LLC raised its position in shares of Corteva by 1.9% during the 3rd quarter. FMR LLC now owns 10,747,791 shares of the company's stock worth $631,863,000 after purchasing an additional 203,126 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.

Remove Ads

Corteva Stock Down 0.2 %

Shares of CTVA traded down $0.13 during mid-day trading on Friday, reaching $61.70. The company's stock had a trading volume of 6,880,464 shares, compared to its average volume of 3,599,087. The business has a fifty day moving average of $62.34 and a 200 day moving average of $59.81. The company has a market cap of $42.30 billion, a price-to-earnings ratio of 47.83, a price-to-earnings-growth ratio of 1.68 and a beta of 0.79. Corteva, Inc. has a 1 year low of $50.01 and a 1 year high of $66.24. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a dividend of $0.17 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. Corteva's dividend payout ratio is 52.71%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CTVA shares. Bank of America increased their price objective on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Oppenheimer increased their price objective on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. Barclays increased their price objective on Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 21st. Royal Bank of Canada increased their price target on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. Finally, The Goldman Sachs Group started coverage on Corteva in a research note on Thursday, March 13th. They set a "buy" rating and a $71.00 price target for the company. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $68.00.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 26,560 shares of the stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares of the company's stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.20% of the stock is owned by corporate insiders.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.